←
KidneyCAN6,177 posts
KidneyCAN avatar✓

KidneyCAN ✓

@kidneycan

Our mission is to accelerate cures for #kidneycancer. We educate patients about clinical trials, advocate for research funding, and bring researchers together.

◷ Joined December 2018▧ 1,908 Photos and videos
KidneyCAN avatar
KidneyCAN@kidneycan·28 Nov 2025

"Without KidneyCAN, without advocates going to the hill, sitting in front of politicians and telling their stories -- there would not have been any funding for kidney cancer." - Dr. @HHammersMD, UTSW Please take a moment to watch our new video, sharing the KidneyCAN story, and how we're working to accelerate cures for #kidneycancer. Support our work: kidneycan.org/donate-now/ @DrChoueiri @CJSTRAV3 @MikeSerzanMD @advocatekidneys

5:05
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 15

Need some direction when it comes to clinical trials? With so many studies, medical terms, and eligibility requirements to navigate, knowing where to start can be challenging. That's where the KidneyCAN Clinical Trial Navigator comes in! Our free, AI-powered tool helps take the guesswork out of your search by identifying potentially relevant #KidneyCancer clinical trials based on your diagnosis, treatment history, and location. Start exploring today: kidneycan.org/clinical-trial… #AcceleratingCures

Post attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 11

This Veterans Day, we honor the brave men and women who have served our country and recognize the lasting impact military service can have on their health. For some veterans, exposure to harmful substances during military service may increase their risk of developing kidney cancer. The PACT Act has helped expand access to healthcare and benefits for veterans affected by certain toxic exposures, but awareness and continued support remain essential. This Veterans Day, consider honoring a veteran in your life with a donation to KidneyCAN. Your gift helps support our mission to #AccelerateCures and improve outcomes for patients and families: kidneycan.org/donate-now/

Post attachmentPost attachmentPost attachmentPost attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 8

Are you living with (or taking care of someone with) advanced kidney cancer (aRCC)? Get paid $150 to share your opinions in a 1-hour remote interview about your treatment experiences. ⏰ Share your advanced kidney cancer treatment experiences in a remote interview 💰 Get paid $150 if you apply & fully complete an interview 🔐 Verify your identity. Insighters do not sell your personal data or sell to you, & everything remains strictly confidential 👉 Interested? Apply here: bit.ly/4iCrdX0

Post attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 8

Only 30% of #KidneyCancer patients globally are asked to consider participating in a clinical trial. But here's an important distinction: Not being asked about a clinical trial doesn't necessarily mean you aren't eligible for one. Many patients may never have a conversation about clinical trials, leaving them unaware of potential opportunities to explore. We believe every patient deserves access to information that can help them make informed decisions about their care. That's why we created the KidneyCAN Clinical Trial Navigator, a free, AI-powered tool that helps patients identify potentially relevant clinical trials based on their individual circumstances. You don't have to wait for someone else to start the conversation. Explore your options: kidneycan.org/clinical-trial… #AcceleratingCures

Post attachment
Global Society of Rare Genitourinary Tumors avatar
⟳ KidneyCAN retweeted
Global Society of Rare Genitourinary Tumors@GTumors·Oct 29

🔬 What is the natural history of sporadic bilateral/multifocal papillary #RCC? A 25-year prospective @theNCI 📈 Median growth: only 1.55 mm/year ⚠️ Metastases occurred in 6.7% — exclusively when the largest tumor was >3 cm 💡 These data provide important benchmarks supporting active surveillance for appropriately selected small tumors and nephron-sparing approaches when intervention is needed. Congratulations to the authors for advancing our understanding of this uncommon clinical entity! 📖 Read here: doi.org/10.1016/j.euo.2026.0… @HFu_MD @markballmd @SandeepGurramMD @montypal @kidneycan

Post attachment
Sarah Scagliarini, MD avatar
⟳ KidneyCAN retweeted
Sarah Scagliarini, MD@SScagliarini_·Nov 2

🇪🇸 #ESMO26, one week later... What’s Up about #RCC?? 📈 Still strong benefit with adjuvant pembro therapy! @DrChoueiri @CPRT65 @tompowles1 💉 Vaccines towards advRCC @BraunMDPhD ➡️ Challenges for ADCs in RCC: the barriers @YujiMiura5 ☢️ The optimal management of Oligo-RCC @ShankarSiva @DrIacovelli 🧬 Proteogenomics, metastatic patterns, and future therapeutic vulnerabilities 💊 @FudanUniversity And Litespark 011, 012, Care 1, Rampart, XmAb819… @myESMO @OncoAlert @IKCCorg @KidneyCancer @kcCURE @kidneycan

Post attachmentPost attachment
Toni Choueiri, MD avatar
⟳ KidneyCAN retweeted
Toni Choueiri, MD@DrChoueiri·Nov 5

New in @TheLancetOncol : outcomes for patients with #RCC brain metastases are changing. In 1,049 patients, median OS was 20 months—up from 9.6–12 months in historical cohorts. Updated Renal GPA predicts survival from 4.8 to 51.2 months. Important message: brain metastases should not automatically exclude patients from clinical trials. Proud to contribute to this international effort led by Paul Sperduto and Minesh Mehta. thelancet.com/journals/lanon… @RifRahmanMD @SanjayAnejaMD @Luke_Pike_MD @TonyWangMD @SteveBraunstein @TugceKutukMD @Rrkotecha @DukeCancer @DukeRadOnc @MiamiCancerInst @BaptistHealthSF

Post attachmentPost attachmentPost attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 4

Caregivers play an essential role in the #KidneyCancer journey, but the challenges they face aren't always visible. On November 12, join the Judy Nicholson Kidney Cancer Foundation for Behind the Care: Real Stories, Real Challenges, Real Support, a FREE virtual conversation focused on the experiences of kidney cancer caregivers. Hear from caregivers as they share their personal stories, the challenges they've faced, and what has helped them along the way. Moderated by Kathy Russell, this conversation is an opportunity to learn from others who understand the realities of caregiving and find connection and support. Learn more and register: jnfkidneycancer.org/behind-t… #AcceleratingCures

Post attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 3

Not all clinical trials use placebos, and when they do, there are safeguards in place to protect participants. Patients are informed about the possibility of receiving a placebo before deciding whether to enroll. Interested in learning more? The KidneyCAN Clinical Trial Navigator can help you find potentially relevant #KidneyCancer clinical trials to discuss with your healthcare team. Explore the free Navigator: kidneycan.org/clinical-trial… #AcceleratingCures

Post attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Nov 3

Calling all early-career cancer researchers! 📣 The deadline to apply for the AACR Scholar-in-Training Awards is coming up on November 10! These awards help support the next generation of cancer researchers by providing opportunities for promising early-career investigators to participate in scientific meetings, share their work, and connect with leaders in the field. Don't miss this opportunity to take the next step in your research career! Learn more about the awards and application requirements: bit.ly/SITA_2026 #AcceleratingCures

Post attachment
KidneyCAN avatar
KidneyCAN@kidneycan·Oct 29

Your next step in exploring clinical trials could be just a few clicks away! Clinical trials are taking place at research centers across the country, but finding one that may be right for you isn't always easy. The KidneyCAN Clinical Trial Navigator helps simplify your search by identifying potentially relevant kidney cancer clinical trials based on your diagnosis, treatment history, and location. Whether you're exploring options close to home or willing to travel, our free, AI-powered tool can help you discover opportunities to discuss with your healthcare team. kidneycan.org/clinical-trial… Start exploring: kidneycan.org/clinical-trial… #AcceleratingCures

Post attachment